Gadsden Properties Quick Ratio (FCRE) starting from the second quarter 2019 to second quarter 2018, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Gadsden Properties, Inc.  (FCRE)

Gadsden Properties's Quick Ratio

FCRE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2019, Quick Ratio fell to 0 a new company low.

Within Medical Equipment & Supplies industry 212 other companies have achieved higher Quick Ratio than Gadsden Properties in second quarter 2019. While Quick Ratio total ranking has improved so far during the Q2 2019 to 5334, from total ranking in the first quarter 2019 at 5391.

Explain Quick Ratio?
How much Cash & cash equivalents FCRE´s has?
What are FCRE´s Current Liabilities?




FCRE Quick Ratio (Jun 30 2019)
Q2
(Mar 31 2019)
Q1
(Dec 31 2018)
Q4
(Sep 30 2018)
Q3
(Jun 30 2018)
Q2
Y / Y Current Liabilities Change 1112.01 % -1.79 % -13.17 % -53.79 % -55.27 %
Y / Y Cash & cash equivalent Change -90.92 % -58.01 % -88 % -63.46 % -61.7 %
Quick Ratio MRQ 0 0.21 0 0.11 0.2
FCRE's Total Ranking # 5334 # 5391 # 2448 # 2665 # 3488
Seq. Current Liabilities Change 1114.8 % -42.75 % 81.86 % -4.18 % -1.56 %
Seq. Cash & cash equivalent Change -91.17 % 15183.33 % -98.69 % -48.54 % -59.16 %



Quick Ratio second quarter 2019 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 213
Healthcare Sector # 978
Overall Market # 5334


Quick Ratio Statistics
High Average Low
1.89 0.56 0
(Mar 31 2013)   (Jun 30 2019)




Financial Statements
Gadsden Properties's Current Liabilities $ 53 Millions Visit FCRE's Balance sheet
Gadsden Properties's Cash & cash equivalent $ 0 Millions Visit FCRE's Balance sheet
Source of FCRE's Sales Visit FCRE's Sales by Geography


Cumulative Gadsden Properties's Quick Ratio

FCRE's Quick Ratio for the trailling 12 Months

FCRE Quick Ratio

(Jun 30 2019)
12 Months
(Mar 31 2019)
12 Months
(Dec 31 2018)
12 Months
(Sep 30 2018)
12 Months
(Jun 30 2018)
12 Months
Y / Y Current Liabilities TTM Growth 159.48 % -35.92 % -49.76 % -59.81 % -56.75 %
Y / Y Cash & cash equivalent TTM Growth -66.61 % -60.92 % -49.43 % -62.77 % -56.22 %
Quick Ratio TTM 0.02 0.11 0.17 0.17 0.17
Total Ranking TTM # 5006 # 2445 # 2688 # 2719 # 4937
Seq. Current Liabilities TTM Growth 236.67 % -0.38 % -5.31 % -18.29 % -16.85 %
Seq. Cash & cash equivalent TTM Growth -35.66 % -35.78 % -1.23 % -18.19 % -24.69 %


On the trailing twelve months basis Due to in Current Liabilities in the Q2 2019 to $52.78 millions, cumulative Quick Ratio decreased to 0.02 below the Gadsden Properties, Inc. average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 210 other companies have achieved higher Quick Ratio than Gadsden Properties. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2019 from 2445 to 5006.

Explain Quick Ratio?
How much Cash & cash equivalents FCRE´s has?
What are FCRE´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 211
Healthcare Sector # 929
Within the Market # 5006


trailing twelve months Quick Ratio Statistics
High Average Low
1.71 0.6 0.05
(Jun 30 2013)   (Jun 30 2019)




Companies with similar Quick Ratio in the quarter ending Jun 30 2019, within Medical Equipment & Supplies Industry Quick RatioJun 30 2019 MRQ Cash & cash equivalentJun 30 2019 MRQ Current Liabilities
Parallax Health Sciences Inc 0.00 $ 0.023  Millions$ 5.748  Millions
Therapeutic Solutions International Inc 0.00 $ 0.007  Millions$ 1.851  Millions
Yubo International Biotech Limited 0.00 $ 0.006  Millions$ 1.704  Millions
Sigyn Therapeutics Inc 0.00 $ 0.009  Millions$ 3.207  Millions
Adynxx, Inc. 0.00 $ 0.024  Millions$ 11.461  Millions
Advanced Biomedical Technologies Inc 0.00 $ 0.011  Millions$ 6.589  Millions
Gadsden Properties, Inc. 0.00 $ 0.081  Millions$ 52.783  Millions
Regenicin Inc 0.00 $ 0.002  Millions$ 3.594  Millions
Skinhealth Systems Inc 0.00 $ 0.000  Millions$ 0.301  Millions

Date modified: 2026-08-29T17:32:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.